Developing a Tailored Neuropsychological Rehabilitation for Sturge-Weber Syndrome
NPS-SWS
Exploring the Neuropsychological Profile of Sturge-Weber Syndrome for Developing Tailored Rehabilitation.
1 other identifier
observational
40
1 country
1
Brief Summary
The goal of this observational study is to learn about the neuropsychological profile of Sturge-Weber Syndrome (SWS) in children and adults with this rare neurocutaneous condition. SWS affects approximately 1 in 50,000 live births and is characterized by brain blood vessel malformations, facial port-wine stains, and abnormal vascularization in the brain, skin, and eyes. Patients are at high risk for epileptic seizures, stroke-like episodes, glaucoma, and motor and cognitive difficulties. The main questions it aims to answer are:
- What are the specific cognitive strengths and weaknesses in visuospatial abilities, working memory, and executive functions in individuals with SWS?
- What is the detailed neuropsychological profile of patients with SWS who do not have intellectual disability?
- Are there different cognitive-behavioral phenotypes between patients with and without the characteristic facial port-wine stain (PWS)?
- How do clinical variables such as seizure history and brain involvement patterns relate to specific cognitive deficits? Participants will undergo a comprehensive neuropsychological assessment battery that includes:
- Intellectual functioning tests (K-BIT2) to measure verbal and non-verbal intelligence
- Executive function evaluation (BRIEF2) assessing behavioral regulation, emotional regulation, and cognitive regulation
- Language assessment including receptive vocabulary (PPVT) and grammatical comprehension (TCGB-2)
- Visuospatial skills testing (Beery-Buktenica VMI) evaluating visual-motor integration
- Working memory assessment (WISC-IV/WAIS-IV digit span and spatial span subtests)
- Learning abilities evaluation including reading (Battery for the Assessment of - Developmental Dyslexia and Dysorthography), writing, and mathematical skills (ABCA test)
- Additional assessments for attention, verbal memory, and spatial memory as needed The study will recruit SWS patients through collaboration with patient associations and Telethon support. Participants will continue their standard medical care throughout the study, and all medications and therapies will be recorded. The neuropsychological testing will be conducted at IRCCS San Raffaele and Sapienza University Department of Psychology. The study aims to identify a cognitive-behavioral phenotype for SWS, develop evidence-based guidelines for neuropsychological monitoring, create personalized recommendations for educational adaptations, produce training materials for healthcare professionals and educators, and establish a multidisciplinary framework for supporting individuals with SWS. This research addresses a critical knowledge gap, as previous studies have focused mainly on general intellectual functioning and the prevalence of intellectual disability and language disorders, without providing detailed neuropsychological profiles, particularly for patients without intellectual disability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 4, 2026
CompletedStudy Start
First participant enrolled
June 10, 2026
CompletedFirst Posted
Study publicly available on registry
June 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
June 17, 2026
June 1, 2026
21 days
June 4, 2026
June 15, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
1. Composite neuropsychological profile across visuospatial, working memory, and executive function domains
Assessment of previously uncharacterized cognitive domains in Sturge-Weber Syndrome using three standardized measures administered at baseline: (1) Beery-Buktenica VMI for visuospatial integration; (2) WISC-IV/WAIS-IV Working Memory Index for working memory capacity; (3) BRIEF2 Global Executive Composite for executive functioning. Each measure is scored according to its own normative standard (standard scores Mean=100 SD=15, or T-scores Mean=50 SD=10), then converted to a uniform z-score scale to allow cross-domain comparison and aggregation into a single composite profile score (mean z-score across the three domains). Performance on the composite is classified as impaired (z \< -1.5), borderline (z between -1.5 and -1.0), average (z between -1.0 and +1.0), or above average (z \> +1.0). Unit of Measure: Mean z-score (composite across three domains)
At baseline assessment
Secondary Outcomes (1)
2. Composite cognitive, linguistic, and academic functioning profile in Sturge-Weber Syndrome
At baseline assessment
Eligibility Criteria
Participants will be recruited through a nationwide network in Italy, primarily through collaboration with the Italian Sturge-Weber Syndrome patient association and support from Fondazione Telethon. The study will be conducted at two primary sites: IRCCS San Raffaele Hospital in Milan and the Department of Psychology at Sapienza University of Rome. Participants include individuals already receiving clinical care for Sturge-Weber Syndrome at specialized neurology and dermatology centers across Italy, as well as individuals identified through patient advocacy organizations. The study aims to recruit a representative sample of the Italian SWS population, including both pediatric patients (children and adolescents) and adults. Given the rarity of SWS (incidence of approximately 0.19 per 100,000 individuals per year), recruitment will occur over an extended period to achieve the target sample size of approximately 40 participants. Outreach will include informational materials distributed
You may qualify if:
- Confirmed diagnosis of Sturge-Weber Syndrome (SWS) of any type (Type I, Type II, or Type III) based on clinical and/or neuroimaging findings
- Age 2 years or older at the time of enrollment (children, adolescents, and adults are eligible)
- Ability to cooperate with neuropsychological testing procedures
- Willingness to complete all study assessments within the designated timeframe
You may not qualify if:
- Absence of confirmed Sturge-Weber Syndrome (SWS)
- Age younger than 2 years at the time of enrollment
- Inability to cooperate with neuropsychological testing procedures even with accommodations or modifications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Roma La Sapienzalead
- IRCCS San Raffaele Romacollaborator
- Fondazione Telethoncollaborator
Study Sites (1)
Department of Psychology University of Rome
Roma, Roma, 00185, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laura Piccardi, PhD
University of Roma La Sapienza
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor
Study Record Dates
First Submitted
June 4, 2026
First Posted
June 17, 2026
Study Start
June 10, 2026
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
June 17, 2026
Record last verified: 2026-06